AGP Executive Report

Epilepsy Drug Update: Stoke Therapeutics and Biogen presented long-term clinical data at the European Epilepsy Congress supporting zorevunersen as a potential disease-modifying treatment for Dravet syndrome, with durable seizure reductions and ongoing improvements in cognition/behavior over up to 28 months. Climate & Health: A new UN report warns the world is likely to exceed the 1.5°C warming threshold, with climate disasters straining public finances and shifting resources away from clean-energy investment; it highlights severe heat impacts, including Japan hospitalizations for heatstroke in July. Heat-Related Risk in Japan: Separate coverage notes Japanese heatstroke risk varies by age and day of the week, underscoring how extreme weather is becoming a more targeted public health challenge. Wellness & Lifestyle Research: Two studies suggest consistent exercise can improve mood and sleep quality, including evidence from large-scale Japanese health checkups. Healthcare Tech/Devices: Control Bionics discusses scaling its EMG-based assistive communication tool through insurance-friendly specialist partners, reflecting how reimbursement shapes medical device adoption. Japan Health Policy: Japan is set to subsidize community efforts to prevent child suicides, aiming to strengthen local prevention capacity. Medical Innovation (Ophthalmology): Alcon launched UNITY M, a premium ophthalmic microscope designed for precise control, pointing to continued upgrades in eye-care tools.

Heat & Health: Japan’s extreme summer heat is pushing people and industries to adapt fast, from “cool biz” style shifts to after-dark farming work as greenhouse temperatures soar and heatstroke risk rises. Climate Risk: The World Meteorological Organization warns El Niño is set to intensify into a very strong event, raising the odds of extreme heat, floods, and drought into 2027. Medical Innovation in Asia: Siemens Healthineers is highlighting AI-enabled, data-connected care pathways at Hospital Management Asia in Bangkok, with a focus on stroke system readiness across ASEAN. Public Health & Safety: Japan’s UNODC-backed counternarcotics programme in Afghanistan (funded by Japan via JICA) targets vulnerable communities with alternative livelihoods and drug prevention/treatment support. Wellness & Lifestyle: A new study explores how humanoid robot touch may influence mood and emotional expression, while Japan’s “Way of Tea” continues to be framed as everyday ritual with mental and social benefits. Food & Supplements Watch: Australia’s krill oil controversy shows how sustainability claims around omega-3 supplements are facing renewed scrutiny from retailers and conservation groups.

Heat & Safety Research: A Toho University team reports heatstroke risk in Tokyo shifts by age and even by the day of the week, with daily routines (work, school, sports, holidays) changing activity patterns under the same heat conditions. Infectious Disease Preparedness: The U.S. government placed its first order for cefiderocol, a reserve antibiotic aimed at hard-to-treat gram-negative infections, signaling growing concern over hospital superbugs. Cancer Drug Updates: Jazz Pharmaceuticals’ partner Akeso reported positive overall survival results for ivonescimab (HARMONi-2) in PD-L1-positive advanced NSCLC, while another report highlights updated overall survival data for zanidatamab-based therapy in HER2+ gastroesophageal adenocarcinoma. Public Health & Climate: A parliamentary health panel warns that climate change, deforestation, poor drainage, and urbanization are helping mosquito-borne diseases spread further across Northeast India. Japan Health Policy Context: Japan’s long-term interest rates hit a 30-year high near 3%, driven by record budget requests and fiscal worries—an economic backdrop that can affect healthcare planning.

Japan Health & Policy: Japan’s 10-year government bond yield has jumped above 3% for the first time in 30 years, raising fresh pressure on Prime Minister Sanae Takaichi’s growth plan and highlighting how fiscal worries can spill into everyday costs. Drug Discovery & Biotech: Ono Pharmaceutical (Osaka) signed a drug discovery partnership with Aitia (Cambridge) to use digital twins for neurological targets, aiming to speed candidate identification and biomarkers. Clinical Research Watch: Newron says it has completed screening for enrollment in its pivotal Phase 3 ENIGMA-TRS 1 trial of evenamide as add-on therapy for treatment-resistant schizophrenia, with topline data expected in Q1 2027. Healthcare Innovation & Ops: Takeda and Weave Bio expanded an AI-driven regulatory automation collaboration, reporting major reductions in drafting time for initial IND submissions and improved performance in health authority question workflows. Global Health Systems: U.S. and Japanese medics trained together in Kanagawa during Big Rescue Kanagawa 2026, tackling mass-casualty triage while managing language and practice differences. Wellness & Lifestyle: A new blood test for Alzheimer’s detection is being discussed, but experts stress it’s not for everyone.

Regenerative Medicine Breakthrough: Japan’s public insurance coverage has expanded to an iPS-cell heart treatment, a major step for regenerative medicine—though questions remain about long-term effectiveness. Neurology Drug Discovery: Ono Pharmaceutical and Aitia announced a collaboration using Aitia’s causal AI “Gemini Digital Twin” platform to identify novel neurological disease drug targets and speed therapeutic development. Nutrition & Brain Health: A Japanese study of 4,171 adults found higher vitamin B2 intake was linked with a lower risk of dementia over 15 years, though researchers stress it shows association, not proof. Aging & Sleep Environment: Research on employed Japanese adults suggests that more enclosed neighborhood street layouts correlate with fewer insomnia symptoms and longer sleep, pointing to how everyday surroundings can shape rest. Food Access for Health Needs: Frozen “bento” meals are gaining traction in Japan, with growth supported by subscription-style home delivery and options aimed at people managing chronic illness or older adults. Clinical Case Spotlight: Surgeons reported a rare ureterosciatic hernia case in Japan where part of the ureter slipped through a pelvic gap, repeatedly causing kidney infections.

Japan Health Policy & Work-Life: Japan will ease administrative pressure on companies to keep monthly overtime within 45 hours from Sept. 1, aiming to help address labor shortages—while unions warn it could nudge workplaces back toward overwork. Japan Health Finance: Japan’s 10-year government bond yield jumped to 3% for the first time since 1996, as markets weigh record budget requests (143 trillion yen) and worsening fiscal health—raising concerns about higher debt-servicing costs. Clinical & Pharma Watch: PharmaEssentia’s Besremi (ropeginterferon alfa-2b-njft) won FDA approval for adults with essential thrombocythaemia, the first ET treatment in nearly 30 years. Women’s Health & Leadership: Arletta Pharma Solutions appointed Jeannette Jager-van Dijk as CEO, as it prepares a U.S. Phase 2 study for Lybrido™. Cancer Pipeline: BlossomHill Therapeutics plans updated Phase 1/2 SOLARA trial data for BH-30643 in EGFR-mutant NSCLC with C797S resistance at the 2026 World Conference on Lung Cancer. Public Health & Safety: Spain recorded a record 5,111 heat-related deaths from June to August, underscoring the health toll of extreme summer heat. Disaster Response: Nepal is seeking more foreign specialized help after the Bhotekoshi disaster, with 903 bodies recovered and about 4,200 still unaccounted for.

Drug Pricing Push: U.S. President Trump announced new Medicaid drug-pricing deals with nine pharma and biotech firms, using “most-favored-nation” discounts aimed at lowering Americans’ prescription costs. Access & Affordability (Japan-linked): Kyowa Kirin said it reached a voluntary agreement with the U.S. government to improve access and lower medicine costs for Medicaid patients under the GENEROUS model, plus a tariff deferral. Alzheimer’s Coverage (Canada): Eisai and Biogen Canada received Canada’s CDA-AMC final positive recommendation for public reimbursement of LEQEMBI (lecanemab) for eligible early Alzheimer’s patients, citing new longer-term data. Medical Tourism: South Korea’s foreign spending on medical services jumped 66.5% year-on-year in July, led by dermatology and plastic surgery, with pharmacy spending rising too. Aging Spotlight: A U.S. Census Bureau report projects the global share of people 65+ will nearly double by 2060, reshaping healthcare demand worldwide. Wellness & Culture: DISCUS and WSET launched online sake courses in the U.S., reflecting growing interest in Japanese beverage education.

Aging & Care: Japan’s oldest resident, 115-year-old Shigeko Kagawa of Nara, has died, with a 114-year-old woman in Kyoto now the country’s oldest person. Health Policy & Costs: Japan’s health ministry plans to exempt extra out-of-pocket charges for OTC-equivalent prescription drugs from consumption tax in its FY2027 tax reform request, aiming to reduce patient burden after a new special-fee system is set to start in March. Wellness & Women’s Health: Six Senses will launch “Yin Way Retreat – The Way of a Woman” in Japan (Kyoto, Dec) and the Maldives (Oct), using Yin principles and menopause/perimenopause framing with sleep and nutrition guidance plus wellness screening. Digital Health & Data: A report forecasts global electronic health records growth to $52.2B by 2030, driven by chronic disease care coordination and government digitization pushes. Medical Tourism Watch: South Korea says foreign spending on medical services rose 66.5% in July, led by dermatology and plastic surgery, with pharmacy spending also climbing. Heat Safety: Tokyo is pushing “Cool Biz” heat countermeasures, promoting shaded-route apps and cooling vests as extreme summer conditions continue.

AI in Public Health: A Japanese team reports it can flag hypertension and diabetes from just a five-second facial video, while another project trains AI on nearly one million retinal scans to estimate dementia risk—both aiming to move screening closer to everyday life, though researchers stress the need for bigger, more diverse validation. Cancer Prevention in Asia: Oita University is helping Bhutan tackle gastric cancer by supporting local production of rapid Helicobacter pylori tests and training doctors for earlier endoscopy detection. Mental Health & Wellness Access: Optimal Healing opened a new Lenox office, expanding accredited talk therapy and planning additional wellness services such as Reiki and other complementary options. Healthcare Innovation for Aging: Kitakyushu held a trial event using an AI testimony response system that lets participants “talk” with A-bomb survivors via curated video clips, with full rollout planned for fiscal 2026. Kidney Disease Trend: Taiwan reported rising kidney-disease deaths and dialysis-related pressures, with clinicians linking the trend to growing multimorbidity and complex medication use. Rare Cancer Drug Approval: The FDA approved Mimrylo (rusfertide) by Takeda for polycythemia vera, a weekly injection to reduce risks from excess red blood cells.

Blood Supply Push: South Sudan’s NBTS director urged regular blood donation, stressing urgent needs for mothers with childbirth complications, accident victims, and gunshot injuries. Cancer Safety Watch: Japanese hematologists warned of sinusoidal obstruction syndrome risk when inotuzumab ozogamicin is combined with ponatinib in Philadelphia-chromosome-positive leukemia patients. Disaster Response & Access: Nepal-China flash floods left 691 dead and nearly 3,000 missing as helicopters and medical tents evacuate survivors; families keep searching at hospitals. Emergency Tracking Gap: A Jiji survey found 45 of 47 Japanese prefectures struggle to track people evacuating in vehicles, raising concerns about getting help to scattered evacuees. Public Health & Care: A Japan-linked report highlights “longevity dividend” thinking—healthy years matter more than lifespan alone—while another notes Japan’s early flu season start. Medical Tourism Trend (Regional): South Korea saw foreign card spending on medical services jump 66.5% in July, with dermatology and plastic surgery still leading. Wellness & Culture: Japan’s Yayoi Kusama, famed for infinity mirror rooms and polka dots, died at 97, with renewed attention on her mental health journey and “self-obliteration” works.

Medical Ethics Scandal: Tokyo University’s medical bribery case highlights how academic prestige, corporate money, and clinical decision-making can blur—raising fresh questions about oversight in Japan’s healthcare system. Cardiology Update: The PREMIUM trial reported prasugrel monotherapy did not meet noninferiority versus dual antiplatelet therapy at the time of primary PCI for STEMI, adding pressure on how long patients should stay on combination therapy. Public Health & Sports: A large study linking race-day air pollution to slower marathon times underscores a real-world health risk for endurance athletes, especially in polluted conditions. Disaster Response (Nepal): Nepal says 626 bodies have been recovered with about 2,400 still unaccounted for after flash floods, while India opened a 24-hour control room and Nepal stresses it needs specialized technical rescue and reconstruction help. Japan Education & Health Workforce Pipeline: University of Tsukuba expanded quotas for foreign undergrads, aiming to boost international enrollment and campus mixing—an indirect lever for future global health talent. Healthcare Tech Infrastructure: A Japanese consortium opened a shared humanoid robot training hub in Chiba, designed to make physical AI training more accessible for mid-market manufacturers.

Exercise & Brain Health: Researchers at the University of Tsukuba report that “very slow” treadmill running—easy enough for many people—can still boost mood and executive function after just 10 minutes. Demographics: Japan’s births rose 0.8% in Jan–June 2026 to 342,068, the first mid-year increase in 11 years, with Tokyo seeing the biggest jump. Public Health & Safety: Japan enters an unusually early flu season, while separate reporting highlights health risks from Legionella in air-conditioning settings. Workforce & Aging: South Korea’s retirement-age debate continues as many workers leave main jobs around age 53, with health cited as a major reason. Disaster Response (Regional, with Japan involved): After Nepal’s Himalayan flash floods, Kathmandu is seeking specialized medical and technical help (tunnel rescue, DNA testing, body storage) while still leading search-and-rescue operations; Japan is among countries offering support. Medical/Health Policy Watch: India is easing 5G EMF limits, a move framed as aligning with international standards and potentially changing how telecoms expand coverage. Sports Health Note: Japan’s Kei Nishikori lost to Rei Sakamoto in US Open qualifying, ending Nishikori’s final-season run.

Medical Device Safety: Nineteen operating tables were recalled in the U.S. after a lock failure could let a patient shift during surgery, including in hybrid neurosurgical suites where tables rotate mid-procedure. Public Health & Vaccines: The FDA approved multiple COVID-19 vaccines for the 2026-2027 season targeting the XFG variant, expanding options for older adults and high-risk patients ahead of fall respiratory virus season. Japan Demographics: Japan’s births rose 0.8% in Jan–June 2026 to 342,068, the first mid-year increase in 11 years, according to health ministry data. Disaster Response (Regional Health Impact): Nepal and China resumed rescue after Himalayan flash floods; Nepal’s missing count rose to 1,924 and deaths to 579, with UNICEF warning that thousands of children were affected and many separated from families. Wellness & Mental Health: A “quiet luxury” travel trend report highlights growing demand for peace and quiet to rest and recharge, reflecting mental health and burnout concerns. Healthcare Workforce/Policy Context: Japan’s early flu season coverage points to shifting respiratory risk timing, raising the stakes for preparedness.

Nepal-Tibet Flood Response: Flash floods on the Nepal–China border have killed at least 543 people and left more than 1,500 missing, with rescue teams briefly halted after a debris-dam overflow risked a secondary surge; hundreds of foreigners were reported among those unaccounted for, and the Red Cross warns the disaster is “not over.” Japan Health Watch: Japan’s influenza season is starting unusually early, with 4,094 flu patients reported in the week through Aug. 23—above the benchmark that signals onset—prompting renewed calls for masks and handwashing. Workplace Safety: Singapore’s Ministry of Manpower is tightening heat-stress rules from Dec. 1, adding requirements like heat training, cool water access, and cold-water or ice-pack standby for outdoor workers. Clinical Pipeline (Japan-relevant): Kowa’s glaucoma eye drop K-911 is headed for FDA review, with an April 30, 2027 action date set—another sign of continued innovation in eye care. Demographics: Japan reported births rose 0.8% in Jan.–June 2026, the first increase in 11 years, though the country’s long-term aging and low fertility pressures remain.

Vaccine Update: Moderna says the U.S. FDA has approved updated 2026-2027 Spikevax and mNEXSPIKE formulas targeting the JN.1-lineage XFG subvariant, aiming to protect high-risk adults and seniors for the coming respiratory season. Cancer Care: Knight Therapeutics filed a supplemental submission to Brazil’s ANVISA under Project Orbis to expand MINJUVI (tafasitamab) plus lenalidomide added to R-CHOP as first-line treatment for untreated DLBCL/HGBL. Ophthalmology Launch Prep: Outlook Therapeutics appointed a new CFO as it prepares for a U.S. commercial launch of LYTENAVA (bevacizumab-vikg) after FDA approval for retinal diseases. Public Health Research: Japan-based trial data adds to HPV prevention for men, with a Lancet Infectious Diseases study reporting large reductions in anal/genital HPV infections after Gardasil 9 vaccination. Mental Health & Community: A Sydney Marathon runner in memory of her father is using the event to raise awareness and funds for mental health support. Disaster Response: Nepal-Tibet floods keep worsening, with reports of hundreds dead and many missing, alongside ongoing emergency and medical assistance efforts.

Medical Innovation (Japan): Nippon Kinzoku has started mass production of ultra-thin, narrow-width stainless steel optimized for laser welding in ultra-fine insulin needles, aiming to support less painful injections and higher adoption of 30G–32G pen needles. Public Health (Japan): Japan’s MOH is still weighing whether to add a dengue vaccine to the National Immunisation Programme, citing the vaccine’s high price and ongoing cost-benefit work before any decision. Health & Safety (Japan): A minor seepage event at China’s Taishan Nuclear Power Station was deemed safe, with no radioactive release and Level 0 classification—relevant for regional health risk monitoring. Global Health (Disaster impact): Catastrophic Nepal–Tibet glacier-collapse floods have killed at least 273 and left more than 1,300 missing, including foreigners—raising urgent concerns about emergency care access and long-term health after mass displacement. Care & Access (Disability support): Samsung Fire & Marine’s guide dog school marked its 33rd anniversary, highlighting ongoing corporate support for independent mobility for blind partners. Mental Health & Culture (Japan): Japanese artist Yayoi Kusama, known for turning mental health struggles into “infinity” art, died at 97, prompting renewed attention to the link between wellbeing and creative coping.